ProstaGene Overview

  • Founded
  • 2010

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $27M

ProstaGene General Information


Developer of a diagnostic test designed to distinguish benign from malignant prostate cancer. The company's prognostic test defines a group of patients with poor outcome based on a signature of gene expression in the patients prostate tumor and it also offers a platform for preclinical testing of therapies for metastatic prostate cancer, enabling patients to early detect and cure cancers.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly Angel backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Social/Platform Software
Parent Company
Primary Office
  • 100 Lancaster Avenue
  • Room 133
  • Wynnewood, PA 19096
  • United States
+1 (267) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProstaGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 16-Nov-2018 $27M 00.00 0000 Completed Generating Revenue
2. Angel (individual) 17-Apr-2016 00000 00.00 Completed Generating Revenue
1. Angel (individual) 19-May-2015 $1M $1M Completed Generating Revenue
To view ProstaGene’s complete valuation and funding history, request access »

ProstaGene Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of a diagnostic test designed to distinguish benign from malignant prostate cancer. The company's prognostic t
Other Healthcare Technology Systems
Wynnewood, PA
000 0000-00-00
000000&0 00.00


or in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint o
Cambridge, MA
000000000. 0 00000

000 00

et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
Birmingham, AL
000000 - 000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ProstaGene Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aurora Biopharma Angel-Backed Cambridge, MA 00000 000000000. 0 00000
000 000000000000 Formerly VC-backed Birmingham, AL 00.000 000000 - 000 00.000
000000 Venture Capital-Backed Rochester, MN 00 00000 00000000000 00000
0000000 Venture Capital-Backed Cambridge, MA 0 0000000000 0
000000 00000000000 Venture Capital-Backed Plymouth Meeting, PA 00 000.00 00000000000 000.00
You’re viewing 5 of 13 competitors. Get the full list »

ProstaGene Executive Team (2)

Name Title Board Seat Contact Info
Richard Pestell Ph.D Founder, Board Member & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

ProstaGene Board Members (1)

Name Representing Role Since
Daniel Matthias ProstaGene Advisor,Board Member & Founding Investor 000 0000
To view ProstaGene’s complete board members history, request access »

ProstaGene Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Rebecca Matthias Angel (individual) Minority 000 0000 000000 0
Thomas Jefferson University University Minority 000 0000 000000 0
To view ProstaGene’s complete investors history, request access »